← Open Payments lookup

NPI 1962433839: Open Payments

NPI 1962433839. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$258 in 16 payments from 3 companies in 2025. Trend: 2023 $465 · 2024 $516 · 2025 $258

Food & beverage: $258
CompanyPaymentsAmount
ABBVIE INC.14$215
VERTEX PHARMACEUTICALS INCORPORATED1$24
Boehringer Ingelheim Pharmaceuticals, Inc.1$19

Products named: UBRELVY, QULIPTA, CREON, JOURNAVX, OFEV, LINZESS.